Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Correction to: Leukemia

https://doi.org/10.1038/s41375-020-0725-0

The original version of this Article contained an error in the spelling of the author Lucienne Michaux, which was incorrectly given as Lucienne Micheaux. This has now been corrected in both the PDF and HTML versions of the Article.

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to G. J. Ossenkoppele.

Additional information

The original article can be found online at https://doi.org/10.1038/s41375-020-0725-0.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ossenkoppele, G.J., Breems, D.A., Stuessi, G. et al. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia (2020). https://doi.org/10.1038/s41375-020-0994-7

Download citation